Showing results (161-170 of 254) with videos related to
Sort By:
Pageof 26
Diabetes Research and Clinical Practice|February 19, 2020
Mortality attributable to diabetes in 20-79 years old adults, 2019 estimates: Results from the International Diabetes Federation Diabetes Atlas, 9<sup>th</sup> editionPouya Saeedi, Paraskevi Salpea, Suvi Karuranga, et al.Aging Clinical and Experimental Research|January 4, 2008
The clinically meaningful change in physical performance scores in an elderly cohortJeri W Nieves, Tracy Li, Marsha Zion, et al.Archives of Internal Medicine|April 14, 2004
Hemoglobin A1c level and future cardiovascular events among womenGavin J Blake, Aruna D Pradhan, JoAnn E Manson, et al.Obesity Research|October 22, 2003
Impact of weight loss and regain on quality of life: mirror image or differential effect?Scott G Engel, Ross D Crosby, Ronette L Kolotkin, et al.Journal of the Royal Society, Interface|July 20, 2006
Calcium-binding phospholipids as a coating material for implant osteointegrationMatteo Santin, William Rhys-Williams, Josephine O'Reilly, et al.Journal of Rehabilitation Research and Development|December 2, 2005
Walking speed predicts health status and hospital costs for frail elderly male veteransJama L Purser, Morris Weinberger, Harvey J Cohen, et al.Advances in Therapy|June 11, 2026
Indirect Comparison of the Efficacy of Zanubrutinib vs Ibrutinib and Acalabrutinib in Treatment-Naive Chronic Lymphocytic Leukemia: 6-Year Follow-UpMazyar Shadman, Talha Munir, Sheng Xu, et al.Oncology and Therapy|March 7, 2026
A Meta-analysis Investigating Response Rates with Continuous Bruton Tyrosine Kinase Inhibitor Monotherapies in the Treatment of B Cell LymphomasPier Luigi Zinzani, Rhys Williams, Mei Xue, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 13, 2022
Real-world effectiveness of dimethyl fumarate versus fingolimod in a cohort of patients with multiple sclerosis using standardized, quantitative outcome metricsCarrie M Hersh, Arman Altincatal, Nicholas Belviso, et al.Clinical Therapeutics|July 14, 2021
Health-Related Quality of Life Among Patients With HR+/HER2- Early Breast CancerCarmen Criscitiello, Dean Spurden, James Piercy, et al.Pageof 26